Infectious Diseases 2024

Infectious Diseases 2024

Huvepharma: Coccidiosis vaccine for turkeys receives conditional licensing

20 April, 2024

The United States Dept. of Agriculture’s Center for Veterinary Biologics has granted Huvepharma® a conditional license for the manufacturing and sale of a new turkey coccidiosis vaccine. The vaccine is the only USDA-approved vaccine with three species of Eimeria, the protozoan species that causes coccidiosis. It is sprayed onto day-old turkey poults in the hatchery. The vaccine contains the live oocysts of E. adenoeides, E. meleagrimitis and E. gallopavonis. Coccidiosis has a significant economic impact on the turkey industry in terms of low production efficiency, poor weight gain, increased therapeutic costs and bird mortality.